Skip to main content
Equibles

VICTORY CAPITAL MANAGEMENT INC

Position in TSHA — Taysha Gene Therapies, Inc.

CIK 1040188 San Antonio, TX
Back to TSHA Full portfolio

Position in TSHA

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$1,345,506
+$470,526 QoQ
Shares Held
197,578
+0.9% QoQ
Ownership
0.061%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#87
of 208 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TSHA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

VICTORY CAPITAL MANAGEMENT INC holds $2,534,997,913 across 158 Biotechnology names. TSHA ranks #68 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,173,152 $1,079,469,792
2 RPRX
Royalty Pharma plc
 3,682,932 $206,501,997
3 INCY
Incyte Corp
 1,480,342 $167,811,569
4 JAZZ
Jazz Pharmaceuticals plc
 686,719 $165,478,677
5 LGND
Ligand Pharmaceuticals Inc
 253,764 $80,212,262
6 REGN
Regeneron Pharmaceuticals, Inc.
 126,343 $78,779,914
7 ALNY
Alnylam Pharmaceuticals, Inc.
 172,842 $52,030,627
8 BNTX
BioNTech SE
 539,787 $50,227,180

All Filings in TSHA

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,345,506 197,578
2026-03-31 $874,980 195,745
2025-12-31 $1,076,702 195,764
2025-09-30 $83,712 25,600
2025-06-30 $58,886 25,492
2025-03-31 $26,433 19,017
2024-12-31 $32,871 19,001
2024-09-30 $40,214 20,007
2024-06-30 $40,458 18,062
2024-03-31 $48,554 16,918
2023-12-31 $27,612 15,600